JP2004315386A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004315386A5 JP2004315386A5 JP2003108690A JP2003108690A JP2004315386A5 JP 2004315386 A5 JP2004315386 A5 JP 2004315386A5 JP 2003108690 A JP2003108690 A JP 2003108690A JP 2003108690 A JP2003108690 A JP 2003108690A JP 2004315386 A5 JP2004315386 A5 JP 2004315386A5
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- acid
- transglycosylation product
- substituents
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
【請求項３】 請求項２における没食子酸の誘導体が、１乃至５個のガロイル基がグルコースに結合したものであることを特徴とする抗微生物剤。
【請求項５】 請求項１乃至４におけるヒドロキシ安息香酸の糖転移物及びヒドロキシケイ皮酸の糖転移物、又はそれらの誘導体が、炭素数１乃至１２の炭化水素基を有する化合物であることを特徴とする抗微生物剤。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003108690A JP4571783B2 (ja) | 2003-04-14 | 2003-04-14 | 抗微生物剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003108690A JP4571783B2 (ja) | 2003-04-14 | 2003-04-14 | 抗微生物剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004315386A JP2004315386A (ja) | 2004-11-11 |
| JP2004315386A5 true JP2004315386A5 (ja) | 2006-05-11 |
| JP4571783B2 JP4571783B2 (ja) | 2010-10-27 |
Family
ID=33470081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003108690A Expired - Fee Related JP4571783B2 (ja) | 2003-04-14 | 2003-04-14 | 抗微生物剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4571783B2 (ja) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5083541B2 (ja) * | 2005-08-12 | 2012-11-28 | ライオン株式会社 | 没食子酸誘導体及びそれを含有する外用剤組成物 |
| CN101209254B (zh) * | 2006-12-29 | 2011-04-20 | 江苏正大天晴药业股份有限公司 | 多羟基没食子酰基-β-D-葡萄糖衍生物的用途 |
| GB0819958D0 (en) * | 2008-10-31 | 2008-12-10 | Provexis Natural Products Ltd | Therapeutic compositions |
| GB0819959D0 (en) | 2008-10-31 | 2008-12-10 | Provexis Natural Products Ltd | Fruit extracts |
| ITTO20110428A1 (it) * | 2011-05-13 | 2012-11-14 | Rottapharm Spa | Esteri dell'acido ialuronico, loro preparazione ed uso in dermatologia |
| IN2014MN02392A (ja) | 2012-04-23 | 2015-08-21 | Univ Oslo | |
| CN103044500B (zh) * | 2012-12-14 | 2016-07-06 | 乐山师范学院 | 一种有机酸的制备及抗菌应用 |
| GB201223365D0 (en) | 2012-12-24 | 2013-02-06 | Provexis Natural Products Ltd | Compositions |
| JP6336424B2 (ja) * | 2015-10-09 | 2018-06-06 | 日清食品ホールディングス株式会社 | 抗菌剤および海洋生物の腸炎ビブリオの感染による疾病を抑制する方法 |
| EP3534725A1 (en) | 2016-11-02 | 2019-09-11 | Provexis Natural Products Limited | Water soluble tomato extract protects against adverse effects of air pollution |
| US20190076335A1 (en) * | 2017-09-12 | 2019-03-14 | IntraMont Technologies, Inc. | Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx |
| CN108653338A (zh) * | 2018-07-12 | 2018-10-16 | 石河子大学 | 没食子中抑制肠道致病菌的有效部位生产方法及用途 |
| CN108904541A (zh) * | 2018-07-12 | 2018-11-30 | 石河子大学 | 没食子中抑制牙周疾病致病菌有效部位的生产方法及用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2997358B2 (ja) * | 1992-01-30 | 2000-01-11 | ポーラ化成工業株式会社 | 皮膚外用剤 |
| JPH08217674A (ja) * | 1995-02-16 | 1996-08-27 | Noda Sangyo Kagaku Kenkyusho | ヒスチジン脱炭酸酵素阻害剤 |
| JP3571111B2 (ja) * | 1995-05-23 | 2004-09-29 | 株式会社ポッカコーポレーション | 抗微生物剤 |
| KR20020089440A (ko) * | 2000-04-11 | 2002-11-29 | 다카라 바이오 가부시키가이샤 | 치료제 |
| WO2002022138A1 (en) * | 2000-09-15 | 2002-03-21 | Cubist Pharmaceuticals, Inc. | Antibacterial agents and methods of identification |
-
2003
- 2003-04-14 JP JP2003108690A patent/JP4571783B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004315386A5 (ja) | ||
| NL300933I2 (nl) | Letermovir | |
| WO2006117885A8 (ja) | 皮膚外用剤 | |
| WO2007010281A3 (en) | Use of thiazole derivatives and analogues in disorders caused by free fatty acids | |
| EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
| HK1081945A1 (en) | Process for the synthesis of 4,5-dimethoxy-1-(methylaminomethyl)-benzocy clobutane, and the use thereof | |
| WO2005116002A3 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
| JP2003520232A5 (ja) | ||
| WO2007009656A3 (de) | Neues 1,4-benzothiazepin-1,1-dioxidderivat mit verbesserten eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung | |
| MXPA05012415A (es) | Inhibidores de glutamina fructosa-3-fosfato amidotransferasa (gfat). | |
| AU2005313582A8 (en) | Malonamide derivatives as inhibitors of gamma-secretase for the treatment of Alzheimer's disease | |
| WO2003053359A3 (en) | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders | |
| EP1340755A4 (en) | AGENT WITH EFFECT AGAINST HELICOBACTER | |
| WO2009064374A8 (en) | Oral formulations of bis(thiohydrazide amides) | |
| WO2006088814A3 (en) | Dosage form and method for sustained release of a substituted pyrazine compound | |
| JP2008513426A5 (ja) | ||
| WO2005112914A3 (en) | Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease | |
| NZ516290A (en) | Substituted phenoxyacetic acids | |
| JP2008513427A5 (ja) | ||
| WO2002028821A3 (de) | Propionsäurederivate mit ppar-alpha aktivierenden eigenschaften. | |
| WO2006071564A3 (en) | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents | |
| WO2006110810A3 (en) | Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine | |
| MX2010002470A (es) | Derivados de dimetilciclohexilo como neutralizadores de malos olores. | |
| WO2002009717A1 (fr) | Remedes contre la dyserection contenant des derives de prostaglandine comme principe actif |